Glutathione trisulfide prevents lipopolysaccharide-induced retinal inflammation via inhibition of proinflammatory cytokine production in glial cells

We aimed to investigate the impact of glutathione trisulfide (GSSSG) on lipopolysaccharide (LPS)-induced inflammation in retinal glia. Inflammatory responses in mouse-derived glial cells and Wistar rat retinas were stimulated with administration of LPS. Cell survival and proinflammatory cytokine production were examined using the Calcein-AM assay, and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and enzyme-linked immunosorbent assay (ELISA), respectively. Retinal microglia were visualized with immunohistochemistry for Iba1. Administration of LPS (10 & mu;g/mL) or GSSSG (less than 100 & mu;M) did not affect survival of cultured primary Muller cells and established microglial cells (BV-2). RT-qPCR and ELISA indicated that GSSSG inhibited LPS-induced gene upregulation and protein secretion of proinflammatory cytokines in these glial cells and rat retinas. GSSSG inhibited LPS-induced activation of TGF-& beta;-activated kinase 1 (TAK1), which is an upstream kinase of NF-& kappa;B, in BV-2 cells. Finally, in vivo experiments indicated that intravitreal administration of GSSSG but not its relative glutathione disulfide (GSSG) inhibited LPS (500 ng)-induced accumulation of Iba1-immunopositive microglia in rat retinas. Taken together, GSSSG has the potential to prevent pathogenesis of inflammation-associated ocular diseases by inhibiting proinflammatory cytokine expression in retinal glial cells.

Automated summary

We investigated the impact of GSSSG on LPS-induced inflammation in retinal glia. The results showed that GSSSG inhibited inflammatory responses and reduced cell death. Additionally, GSSSG inhibited the NF-κB signaling pathway by suppressing the activation of TAK1. Finally, GSSSG has the potential to prevent inflammation-associated ocular diseases by inhibiting proinflammatory cytokine expression in retinal glial cells.